Masthead

Articles in Press

Issue Highlights

EJC Podcasts

video still

Listen Now

Richard Marais (Cancer Research UK Manchester Institute, UK) finds that circulating cell-free DNA is a surrogate marker of tumour burden in patients with metastatic melanoma. He tells Helen Saul that a simple blood test could predict overall survival.

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

video still

Listen Now

Eric Lim (Royal Brompton and Harefield NHS Trust, London, UK) finds that lung cancer among never-smokers is increasing dramatically. He tells Helen Saul that if trends continue, never-smokers diagnosed with lung cancer could outnumber smokers within the next 10 years.

Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK

video still

Listen Now

Yolande Lievens (Ghent University Hospital, Belgium) finds that radiotherapy is underutilised even in Belgium, one of the best-resourced countries in Europe. She discusses with Helen Saul a collaborative project involving the Belgium Cancer Registry and the College for Physicians in Radiation Oncology.

Radiotherapy access in Belgium: How far are we from evidence-based utilisation?

video still

Listen Now

Simon Pernot (Hôpital Européen Georges-Pompidou, Paris France) says that circulating tumour cells may be a valuable prognostic biomarker in advanced gastric cancer. He tells Helen Saul that the new results could improve the management of treatment.

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

View all European Journal of Cancer Podcasts

About

European Journal of Cancer

Cover Image - European Journal of Cancer, Volume 161, Issue
The European Journal of Cancer (EJC) integrates preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.

The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

Society Information

Metrics

Metrics

##
Impact Factor
##
5-Year Impact Factor
##
Eigenfactor Score

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)

Advertisement